HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Vitamin E inhibits abdominal aortic aneurysm formation in angiotensin II-infused apolipoprotein E-deficient mice.

AbstractBACKGROUND:
Abdominal aortic aneurysms (AAAs) in humans are associated with locally increased oxidative stress and activity of NADPH oxidase. We investigated the hypothesis that vitamin E, an antioxidant with documented efficacy in mice, can attenuate AAA formation during angiotensin II (Ang II) infusion in apolipoprotein E-deficient mice.
METHODS AND RESULTS:
Six-month-old male apolipoprotein E-deficient mice were infused with Ang II at 1000 ng/kg per minute for 4 weeks via osmotic minipumps while consuming either a regular diet or a diet enriched with vitamin E (2 IU/g of diet). After 4 weeks, abdominal aortic weight and maximal diameter were determined, and aortic tissues were sectioned and examined using biochemical and histological techniques. Vitamin E attenuated formation of AAA, decreasing maximal aortic diameter by 24% and abdominal aortic weight by 34% (P<0.05, respectively). Importantly, animals treated with vitamin E showed a 44% reduction in the combined end point of fatal+nonfatal aortic rupture (P<0.05). Vitamin E also decreased aortic 8-isoprostane content (a marker of oxidative stress) and reduced both aortic macrophage infiltration and osteopontin expression (P<0.05, respectively). Vitamin E treatment had no significant effect on the extent of aortic root atherosclerosis, activation of matrix metalloproteinases 2 or 9, serum lipid profile, or systolic blood pressure.
CONCLUSIONS:
Vitamin E ameliorates AAAs and reduces the combined end point of fatal+nonfatal aortic rupture in this animal model. These findings are consistent with the concept that oxidative stress plays a pivotal role in Ang II-driven AAA formation in hyperlipidemic mice.
AuthorsDan Gavrila, Wei Gen Li, Michael L McCormick, Manesh Thomas, Alan Daugherty, Lisa A Cassis, Francis J Miller Jr, Larry W Oberley, Kevin C Dellsperger, Neal L Weintraub
JournalArteriosclerosis, thrombosis, and vascular biology (Arterioscler Thromb Vasc Biol) Vol. 25 Issue 8 Pg. 1671-7 (Aug 2005) ISSN: 1524-4636 [Electronic] United States
PMID15933246 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Antioxidants
  • Apolipoproteins E
  • Lipids
  • Sialoglycoproteins
  • Spp1 protein, mouse
  • Vasoconstrictor Agents
  • Osteopontin
  • Angiotensin II
  • Vitamin E
  • 8-epi-prostaglandin F2alpha
  • Dinoprost
  • Matrix Metalloproteinase 2
  • Matrix Metalloproteinase 9
Topics
  • Angiotensin II (pharmacology)
  • Animals
  • Antioxidants (pharmacology)
  • Aorta, Abdominal (metabolism, pathology)
  • Aortic Aneurysm, Abdominal (metabolism, pathology, prevention & control)
  • Aortic Rupture (metabolism, pathology, prevention & control)
  • Apolipoproteins E (genetics)
  • Blood Pressure (drug effects)
  • Dinoprost (analogs & derivatives, metabolism)
  • Hyperlipidemias (genetics, metabolism, pathology)
  • Lipids (blood)
  • Macrophages (pathology)
  • Male
  • Matrix Metalloproteinase 2 (metabolism)
  • Matrix Metalloproteinase 9 (metabolism)
  • Mice
  • Mice, Mutant Strains
  • Osteopontin
  • Oxidative Stress (drug effects)
  • Sialoglycoproteins (metabolism)
  • Vasoconstrictor Agents (pharmacology)
  • Vitamin E (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: